INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 211 filers reported holding INSMED INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $980 | +58.3% | 38,840 | +33.2% | 0.00% | +100.0% |
Q2 2023 | $619 | +50.6% | 29,150 | +20.8% | 0.00% | 0.0% |
Q1 2023 | $411 | +200.0% | 24,125 | +253.3% | 0.00% | – |
Q4 2022 | $137 | -99.9% | 6,828 | +17.4% | 0.00% | – |
Q3 2022 | $125,000 | +8.7% | 5,817 | 0.0% | 0.00% | – |
Q2 2022 | $115,000 | -20.7% | 5,817 | 0.0% | 0.00% | – |
Q1 2022 | $145,000 | -8.2% | 5,817 | 0.0% | 0.00% | – |
Q4 2021 | $158,000 | -1.9% | 5,817 | 0.0% | 0.00% | – |
Q3 2021 | $161,000 | -2.4% | 5,817 | 0.0% | 0.00% | – |
Q2 2021 | $165,000 | -30.4% | 5,817 | -17.1% | 0.00% | -100.0% |
Q1 2021 | $237,000 | +1.7% | 7,015 | 0.0% | 0.00% | – |
Q4 2020 | $233,000 | +3.1% | 7,015 | 0.0% | 0.00% | – |
Q3 2020 | $226,000 | +17.7% | 7,015 | 0.0% | 0.00% | – |
Q2 2020 | $192,000 | +113.3% | 7,015 | +25.0% | 0.00% | – |
Q1 2020 | $90,000 | -32.3% | 5,611 | 0.0% | 0.00% | – |
Q4 2019 | $133,000 | -42.2% | 5,611 | -37.7% | 0.00% | -100.0% |
Q2 2019 | $230,000 | -34.1% | 9,005 | -25.2% | 0.00% | 0.0% |
Q1 2019 | $349,000 | +211.6% | 12,042 | +35.9% | 0.00% | – |
Q4 2018 | $112,000 | -37.4% | 8,861 | 0.0% | 0.00% | – |
Q3 2018 | $179,000 | -14.8% | 8,861 | 0.0% | 0.00% | – |
Q2 2018 | $210,000 | -13.6% | 8,861 | -17.8% | 0.00% | -100.0% |
Q1 2018 | $243,000 | -27.5% | 10,775 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $335,000 | +59.5% | 10,775 | +56.6% | 0.00% | 0.0% |
Q3 2017 | $210,000 | +78.0% | 6,882 | 0.0% | 0.00% | – |
Q2 2017 | $118,000 | -1.7% | 6,882 | 0.0% | 0.00% | – |
Q1 2017 | $120,000 | +31.9% | 6,882 | 0.0% | 0.00% | – |
Q4 2016 | $91,000 | -54.5% | 6,882 | -50.0% | 0.00% | – |
Q3 2016 | $200,000 | +194.1% | 13,764 | +100.0% | 0.00% | – |
Q2 2016 | $68,000 | -21.8% | 6,882 | 0.0% | 0.00% | – |
Q1 2016 | $87,000 | -30.4% | 6,882 | 0.0% | 0.00% | – |
Q4 2015 | $125,000 | -2.3% | 6,882 | 0.0% | 0.00% | -100.0% |
Q3 2015 | $128,000 | -23.8% | 6,882 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $168,000 | +17.5% | 6,882 | 0.0% | 0.00% | – |
Q1 2015 | $143,000 | +34.9% | 6,882 | 0.0% | 0.00% | – |
Q4 2014 | $106,000 | – | 6,882 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |